Research

The Freiberg lab engages in a wide range of research activities including basic science, clinical, translational, and reverse translational projects with the ultimate goal of improving the treatment of bacterial infections in patients.  

We are involved in several ongoing projects in the lab, detailed below.

The Freiberg lab is actively involved in clinical research regarding the appropriate use of antimicrobials. This includes research focused on the use of rapid MRSA diagnostics to guide antibiotic selection.

Dr. Freiberg currently serves as the PI for the STOP-Vanc randomized controlled trial (RCT) along with being involved in a national network of investigators studying the treatment of Multidrug Resistant (MDR) pathogens.